Investing.com - GW Pharma ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GW Pharma ADR announced earnings per share of $-0.02 on revenue of $121.3M (NYSE:MMM). Analysts polled by Investing.com anticipated EPS of $-0.04 on revenue of $120.15M.
GW Pharma ADR shares are up 26.68% from the beginning of the year and are trading at $120.00 , down-from-52-week-high.They are outperforming the Nasdaq which is up 23.8% from the start of the year.
GW Pharma ADR shares lost 9.41% in after-hours trade the report.
GW Pharma ADR follows other major Healthcare sector earnings this month
GW Pharma ADR's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar